Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation

Background: From May to December 2021, Bangladesh experienced a major surge in the Delta variant of SARS-CoV-2. The earlier rollout of several vaccines offered the opportunity to evaluate vaccine effectiveness against this variant. Methods: A prospective, test-negative case-control study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanam, Farhana, Islam, Md Taufiqul, Ahmmed, Faisal, Ahmed, Shams Uddin, Hossen, Md Ismail, Rajib, MdNazmul Hasan, Haque, Shahinur, Biswas, Prasanta Kumar, Tauheed, Imam, Zaman, K, Alam, Ahmed Nawsher, Billah, Mallick Masum, , Monalisa, Ashrafi, Shah Ali Akbar, Rahman, Mohammed Ziaur, Bin Manjur, Omar Hamza, Afrad, Mokibul Hassan, Shamsuzzaman, S M, Saleh, Ahmed Abu, Sumon, Mostafa Aziz, Rashed, Asif, Bhuiyan, Md Taufiqur Rahman, Chowdhury, Fahima, Khan, Ashraful Islam, Flora, Meerjady Sabrina, Shirin, Tahmina, Clemens, John D., Qadri, Firdausi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780914/
https://www.ncbi.nlm.nih.gov/pubmed/36560479
http://dx.doi.org/10.3390/vaccines10122069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780914/
https://www.ncbi.nlm.nih.gov/pubmed/36560479
http://dx.doi.org/10.3390/vaccines10122069

Ejemplares similares